Echo Therapeutics
(NASDAQ: ECTE)
2.74
-0.02
-0.72%
-0.02
-0.72%
MORE ON ECTE
COMPANY INFORMATION
| Exchange: | NASDAQ national market |
| Stock: | Echo Therapeutics, Inc. |
| Industry: | Drug Manufacturers - Major |
| Employees: | 44 |
DESCRIPTION
| Echo Therapeutics, Inc., is a transdermal medical device company with advanced skin permeation technology. The Company is developing its Symphony® CGM System (‘Symphony’) as a non-invasive, wireless continuous glucose monitoring (‘CGM’) system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System (‘Prelude’), a component of Symphony CGM System, allows for enhanced skin permeation that enables extraction of analytes such as glucose. Prelude’s platform skin preparation technology also allows for needle-free, transdermal drug delivery. Additional applications for needle-free analyte extraction and topical and systemic drug delivery are also planned. It is developing Prelude as a safe, effective, easy-to-use and low-cost transdermal skin preparation device for Symphony to enhance the access to the interstitial fluids and enhance the flow of molecules across the protective membrane of the stratum corneum, the outmost protective layer of the skin. The Company own or have rights to various copyrights, trademarks and trade names used in its business, including the following: Symphony® tCGM System, Prelude® SkinPrep System, AzoneTS™ and Durhalieve™. The markets for glucose monitoring and drug delivery devices are particularly competitive, subject to rapid change and are affected by new product introductions and other market activities of industry participants. In the United States, pharmaceuticals, biologics and medical devices are subject to rigorous FDA regulation. |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] The major averages ended higher across the board as the S&P 500 advanced 0.8%. Equities climbed steadily since the opening bell as investors prepared for tomorrow's policy decision from the Federal Reserve. Although chatter in recent w
...
More
MORE MARKET NEWS
Sponsored by: